0001209191-20-039407.txt : 20200630
0001209191-20-039407.hdr.sgml : 20200630
20200630131342
ACCESSION NUMBER: 0001209191-20-039407
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200626
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NARACHI MICHAEL
CENTRAL INDEX KEY: 0001380022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 201001666
MAIL ADDRESS:
STREET 1: C/O OREXIGEN THERAPEUTICS, INC.
STREET 2: 3344 N TORREY PINES CT, #200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-26
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001380022
NARACHI MICHAEL
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
1
0
0
0
Common Stock
2020-06-26
4
A
0
2550
0.00
A
12300
D
Stock Option (Right to Buy)
76.58
2020-06-26
4
A
0
4250
0.00
A
2030-06-26
Common Stock
4250
4250
D
Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021
The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021.
/s/ Karah Parschauer, attorney-in-fact
2020-06-30